Loading clinical trials...
Loading clinical trials...
Evaluation of the Efficacy and Safety of the Cervical Posterior Fixation System PASS OCT®
Prospective, multicenter non comparative and observational study (post-market clinical follow-up). Patients operated with PASS OCT® manufactured by MEDICREA® INTERNATIONAL between July 2016 and July 2017. The inclusion period will be 12 months and the follow-up 24 months
The primary endpoint is to evaluate the safety of the PASS OCT® system. The secondary endpoints are to analyze the efficacy of the system with several point of view: * The quality of fusion and the time of fusion through X rays * the pain with VAS * the quality of life thanks to questionnaires: NDI (Neck Disability Index) and JOA for myelopathy * the daily of the patient: return to work, sport * the surgeon satisfaction.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Hopital la Timone
Marseille, France
Start Date
October 1, 2016
Primary Completion Date
January 1, 2022
Completion Date
January 1, 2022
Last Updated
November 27, 2023
40
ESTIMATED participants
PASS OCT® Spinal System
DEVICE
Lead Sponsor
Medicrea International
NCT04992572
NCT06886802
NCT05029726
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions